Abstract:Background: Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease in women, while the oncogenic mechanisms which contribute to TNBC development, progression, and metastasis are poorly investigated and therefore warrant the critical need to identify novel oncogenic signalings and develop new therapeutic targets. Results: We show that Zinc Fingers and Homeoboxes 2 (ZHX2) is amplified or overexpressed in TNBC cell lines and patients. Functionally, depletion of ZHX2 inhibited TNBC cell growth and invasion in vitro, orthotopic tumor growth, and spontaneous lung metastasis in vivo. Mechanistically, ZHX2 bound with hypoxia-inducible factor (HIF) family members and positively regulated HIF1α protein level and activity in TNBC. Integrated ChIP-seq and gene expression profiling demonstrated that ZHX2 co-occupied with HIF1α on transcriptionally active promoters marked by H3K4me3 and H3K27ac, thereby promoting gene expression. Among the identified ZHX2 and HIF1α coregulated genes, overexpression of AP2B1, COX20, KDM3A, or PTGES3L could partially rescue TNBC cell growth defect by ZHX2 depletion, suggesting that these downstream targets contribute to the oncogenic role of ZHX2 in an accumulative fashion. Furthermore, multiple residues (R491, R581, and R674) on ZHX2 are important in regulating its phenotype, which correspond with their roles in controlling ZHX2 transcriptional activity in TNBC cells. These studies establish that ZHX2 activates oncogenic HIF1α signaling, therefore serving as a potential therapeutic target for TNBC. Conclusion: ZHX2 has been highlighted as one critical hypoxia-related factors regulator contributing to triple-negative breast cancer in this work, which has enriched the upstream regulatory network of HIF-1α signaling. Moreover, identification of key residuals determining biological function of ZHX2 provides novel approaches for treating TNBC via targeting the hypoxia pathway. Citation Format: Chengheng Liao, Wentong Fang, Rachel Shi, Jeremy Simon, Travis Ptacek, Giada Zurlo, Youqiong Ye, Leng Han, Cheng Fan, Lei Bao, Christopher Llynard Ortiz, Hong-Rui Lin, Ujjawal Manocha, Weibo Luo, Yan Peng, William Y Kim, Lee-Wei Yang, Qing Zhang. ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl) nr P4-08-23.

HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells

Hif-1 Alpha Activates Hypoxia-Induced Bcl-9 Expression In Human Colorectal Cancer Cells

Hypoxia Induce BCL9 Promote Colorectal Cancer Proliferation and Migration

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma

Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells.

HIF-2 alpha mediates hypoxia-induced LIF expression in human colorectal cancer cells

BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α

HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.

BCL9 Provides Multi-Cellular Communication Properties in Colorectal Cancer by Interacting with Paraspeckle Proteins

Hypoxia-inducible Factor-1Alpha Modulates the Down-Regulation of the Homeodomain Protein CDX2 in Colorectal Cancer.

BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}.

DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway

Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma

Pharmacological Inhibition and Genetic Knockdown of BCL9 Modulate the Cellular Landscape of Cancer-Associated Fibroblasts in the Tumor-Immune Microenvironment of Colorectal Cancer

Zinc Finger Protein 91 (ZFP91) Activates HIF-1α Via NF-κB/p65 to Promote Proliferation and Tumorigenesis of Colon Cancer.

P4HA1 regulates human colorectal cancer cells through HIF1α-mediated Wnt signaling

HIF-1α-induced Histone Demethylase JMJD2B Contributes to the Malignant Phenotype of Colorectal Cancer Cells Via an Epigenetic Mechanism

ZDHHC9 Promotes Colon Tumor Growth by Inhibiting Effector T Cells.

Inhibition of BCL9 Modulates the Cellular Landscape of Tumor-Associated Macrophages in the Tumor Immune Microenvironment of Colorectal Cancer.

Hif-1 Alpha And Taz Serve As Reciprocal Co-Activators In Human Breast Cancer Cells